AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

183.150

+2.7801.54%

Volume:157.60K

Turnover:28.84M

Market Cap:88.86B

PE:21.03

High:184.340

Open:181.900

Low:181.350

Close:180.370

52wk High:272.649

52wk Low:168.000

Shares:485.15M

Float Shares:483.95M

Volume Ratio:0.85

T/O Rate:0.03%

Dividend:4.26

Dividend Rate:2.33%

EPS(TTM):8.710

EPS(LYR):8.710

ROE:15.37%

ROA:6.63%

PB:3.26

PE(LYR):21.03

Loading ...

Overview Company News Filings

Concept

Novel Coronavirus Treatment+0.80%

Pharmaceutical Companies+1.36%

ESG Concept+0.51%

Capital Flow

Inflow:

Outflow:

News

BUZZ-CSL's Memo deal signals new R&D philosophy, Jefferies says

BRIEF-Memo Therapeutics AG Enters Into A Collaboration And Option Agreement With Csl For Development Of Recombinant Polyclonal Igg Technology

Memo Therapeutics Ag Enters Into a Collaboration and Option Agreement With CSL for Development of Recombinant Polyclonal Igg Technology

THOMSON REUTERS

Memo Therapeutics Ag: Agreement Includes R&D Funding for Exploratory Work, Technology Access

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CSL.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":183.15,"timestamp":1770682084951,"preClose":180.37,"halted":0,"volume":157599,"delay":0,"changeRate":0.015412762654543444,"nameEN":"CSL LIMITED","floatShares":483950454,"shares":485151394,"eps":8.71022201893662,"marketStatus":"Trading","change":2.78,"latestTime":"02-10 11:08:09 AEDT","open":181.9,"high":184.34,"low":181.35,"amount":28835988,"amplitude":0.016577,"askPrice":183.15,"askSize":18,"bidPrice":183.11,"bidSize":28,"shortable":3,"etf":0,"ttmEps":8.71022201893662,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770699600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":180.37,"dividendRate":0.023259,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":0.847123,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":483950454,"roa":"6.63%","roe":"15.37%","lyrEps":8.710222,"volumeRatio":0.847123,"shares":485151394,"dividePrice":4.2598,"high":184.34,"amplitude":0.016577,"preClose":180.37,"low":181.35,"week52Low":168,"pbRate":"3.26","psRate":"4.05","week52High":272.649,"institutionHeld":0,"latestPrice":183.15,"committee":0.217391,"eps":8.71022201893662,"divideRate":0.023259,"volume":157599,"delay":0,"ttmEps":8.71022201893662,"open":181.9,"prevYearClose":172.65,"prevWeekClose":180.5,"prevMonthClose":181.42,"prevQuarterClose":172.65,"fiveDayClose":178.11,"twentyDayClose":175.1,"sixtyDayClose":179.06,"earningDate":1770739200000,"dividendPayoutRate":0.4488044711953849,"dividendGrowthYears":4,"dividendGrowthRate":0.11620984529927163,"fiveYearAvgDividendRate":0.013182154300910737},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770764400000,"name":null,"time":"","dateTimestamp":1770728400000,"actualEps":null},{"date":"2025-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-10","defaultRemindTime":1757376000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-03","payableDate":"2025-09-10","currency":"USD","dateTimestamp":1757340000000,"payDate":"2025-10-03"},{"date":"2025-08-19","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755561600000,"name":null,"time":"","dateTimestamp":1755525600000,"actualEps":null},{"date":"2025-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2025-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-09","payableDate":"2025-03-11","currency":"USD","dateTimestamp":1741525200000,"payDate":"2025-04-09"},{"date":"2025-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739228400000,"name":null,"time":"","dateTimestamp":1739192400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610683756","title":"BUZZ-CSL's Memo deal signals new R&D philosophy, Jefferies says","url":"https://stock-news.laohu8.com/highlight/detail?id=2610683756","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610683756?lang=en_us&edition=fundamental","pubTime":"2026-02-10 02:40","pubTimestamp":1770662451,"startTime":"0","endTime":"0","summary":"BUZZ-CSL's Memo deal signals new R&D philosophy, Jefferies says** Jefferies says Australia's CSL CSL.AX sees its new agreement with Switzerland-based Memo Therapeutics as \"evidence\" that the biotech major is now focusing on development by buying assets into its pipeline** Memo on Monday said it entered into a collaboration and option agreement with CSL for development of recombinant polyclonal IgG technology, a method used to clone antibodies** Jefferies notes CSL is looking to reenergise its research function in the longer term; however, flags it will likely take time, given the nature of R&D** Brokerage adds Memo deal could help with CSL's product growth in the medium term, following co's VarmX deal last year** CSL up 4.5% so far this year, as of last close","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nL4N3Z51TF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7067","BK7511","BK7508","CSL.AU"],"gpt_icon":0},{"id":"2610637722","title":"BRIEF-Memo Therapeutics AG Enters Into A Collaboration And Option Agreement With Csl For Development Of Recombinant Polyclonal Igg Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2610637722","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610637722?lang=en_us&edition=fundamental","pubTime":"2026-02-09 20:18","pubTimestamp":1770639539,"startTime":"0","endTime":"0","summary":"BRIEF-Memo Therapeutics AG Enters Into A Collaboration And Option Agreement With Csl For Development Of Recombinant Polyclonal Igg TechnologyFeb 9 (Reuters) - CSL Ltd CSL.AX:MEMO THERAPEUTICS AG ENTER","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z515R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7511","BK7508","CSL.AU","BK7501"],"gpt_icon":0},{"id":"2610463745","title":"Memo Therapeutics Ag Enters Into a Collaboration and Option Agreement With CSL for Development of Recombinant Polyclonal Igg Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2610463745","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610463745?lang=en_us&edition=fundamental","pubTime":"2026-02-09 20:09","pubTimestamp":1770638958,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z515R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7067","CSL.AU","BK7508","BK7511"],"gpt_icon":0},{"id":"2610374296","title":"Memo Therapeutics Ag: Agreement Includes R&D Funding for Exploratory Work, Technology Access","url":"https://stock-news.laohu8.com/highlight/detail?id=2610374296","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610374296?lang=en_us&edition=fundamental","pubTime":"2026-02-09 20:09","pubTimestamp":1770638958,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z515R:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7501","CSL.AU","BK7067","BK7508"],"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":199,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CSL.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Novel Coronavirus Treatment","bkCode":"BK7501","id":"package_au_concept_xgzlg","changeRate":0.008011},{"market":"AU","name":"Pharmaceutical Companies","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":0.013626},{"market":"AU","name":"ESG Concept","bkCode":"BK7511","id":"package_au_concept_esggn","changeRate":0.005117}]}}